SourceOne Debuts Patented Omega-3 Emulsion Technology and Study Results at IFT Conference

SourceOne Global Partners and Omega-3 partner FINA has announced that it will present new research results on its range of concentrated U.S. produced Omega-3s fatty acids, edible oils, and natural products at the IFT Food Expo this July 17-20 in Chicago – booth 7437. The annual IFT Food Expo, which brings together tens of thousands of food professionals from around the globe, showcases the latest products, techniques, tools ,and trends that can be found in the food science and technology industry.

Jesse Lopez, CEO and founder of SourceOne said the company will introduce results of new studies on its VESIsorb® technology platform at IFT, a patented natural self-emulsifying colloidal delivery system that has been clinically proven to increase absorption and bioavailability of Omega-3, CoQ10 and Resveratrol as key ingredients in beverages, functional foods, and nutraceutical formulations. “This patented technology broadens food application for these bioactives,” he explained, “and enables us to meet the growing demand for enhanced bioavailability of unique science-based ingredients and proprietary formulas taking their absorption and efficacy to the next level. In addition to our unparalleled lineup of OmegaChoice concentrated Omega-3 EPA / DHA fish oils; SourceOne has raised the bar for innovation in Omega-3 with the VESIsorb® technology.”

In partnership with FINA, SourceOne’s proprietary Omega-3 technologies and beverage emulsion capabilities provide a strong foundation to meet the growing demand in food, nutritional supplement and pharmaceutical markets for higher Omega-3 EPA and DHA concentrations. FINA focuses on Omega-3s in the natural triglyceride form, which is the form of Omega-3 Fatty Acids naturally found in the food we eat. Josipa Paska, FINA CEO commented, “The implementation of this technology allows us to broaden the omega choice line of concentrated EPA/DHA Omega-3s to include this proprietary technology.”

She added, “The rapidly growing demand for more pure and highly concentrated Omega-3 triglycerides represents a great opportunity for us to meet the needs of the quickly evolving trend of choosing Omega-3 triglycerides over ethyl esters. Our expertise in Omega-3 technology and production will enable us to deliver exceptional value in the natural products market place.” According to Paska, FINA’s production capacity is greater than the combined total of all Omega-3 suppliers worldwide. “Higher purity and better stability with less odor and fishy taste afford broader applications, consumer appeal, and ultimately consumption,” she emphasized.

A recent study in humans comparing the absorption and bioavailability of OmegaChoice™ 90 Concentrated Omega-3 EPA to the same OmegaChoice™ 90 in the VESIsorb® delivery system. The pharmacokinetic pilot study (single oral dose, crossover) demonstrated an increase of 567% in peak blood levels (cmax) of EPA in the formula that utilized the naturally self-assembling VESIsorb® delivery system. The relative bioavailability calculated using the area under the curve (AUC0-12h) was also increased by 487%.

Developed by Vesifact of Baar, Switzerland, VESIsorb® is protected worldwide by multiple U.S. and international granted and pending patents. Marc Weder, CEO of Vesifact, explained that “stability oxidation broadens the applications for key bioactives like Omega 3 EFAs, Coq10, bioflavanoids and more active nutraceuticals. We can offer these benefits with OmegaChoice Concentrated Omega-3 EPA/DHAin either oil form applications or in a powder form for drink mixes, stick packs, beverages, food products and more.”

About SourceOne Global Partners:

SourceOne Global Partners, headquartered in Chicago, IL, is a leading supplier of innovative, science-based, branded ingredients and proprietary formulas to the nutritional supplement, functional food & beverage, cosmetic, and animal nutrition markets. SourceOne has assembled an impressive and enviable portfolio of complementary condition-specific ingredients that address the most pressing health concerns, including heart health, Type II diabetes, cognitive function, diet and energy, and general wellness.

SourceOne is recognized as a leader in delivering the best science nature has to offer through health solutions such as the award-winning Cholesstrinol™ Family of Heart Healthy Formulas, OmegaChoice™ Marine Concentrated Omega-3 EPA/DHA (EFAs), CoQsource® Bio-Enhanced Coenzyme Q10, and SterolSource® Phytosterols. The SourceOne product line continues to expand and also includes TocoSource® Palm Tocotrienols, GammaSource® Mixed Tocopherols, PMF-source™ Citrus Flavonoids (PMF), Tongkat Ali-Source™ as well as Green Tea, Resveratrol, Chondroitin, and more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish